FDA
-
-
-
-
-
-
-
FDA Approves XBiotech’s IND in Rheumatology
-
-
-
-
-
-
-
XBiotech Candidate True Human™ COVID-19 Therapy Found to Target Highly Infectious Emerging Strain
-
-
-
-
-
-
-
XBiotech-Developed COVID-19 Test Supports Convalescent Blood Treatments Now Approved Under FDA Emergency Use Authorization
-
-
-
-
-
-
-
XBiotech Adds Dr. Peter Libby, Renowned Cardiologist and Research Pioneer in Inflammation and Cardiovascular Disease, to its Corporate Board
-
-
-
-
-
-
-
Phase 2 Clinical Trial of Bermekimab Shows Potential New Standard of Care for Treatment of Hidradenitis Suppurativa, Including Significant Pain Reduction without Antibiotics
-
-
-
-
-
-
-
Bermekimab Successfully Treats Hidradenitis Suppurativa, Including Significant Reduction in Pain
-
-
-
-
-
-
-
Pre-Open Movers 09/13: (PI) (XBIT) (GNC) Higher; (PVTL) (PGNX) (FRED) Lower (more...)
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

